| 0.772 | 0.004 | 0.772 | Anticonvulsant | | |
| 0.727 | 0.005 | 0.727 | Spasmolytic | | |
| 0.543 | 0.009 | 0.543 | Vasodilator | | |
| 0.471 | 0.02 | 0.471 | Vasodilator, coronary | | |
| 0.445 | 0.016 | 0.445 | Psychostimulant | | |
| 0.409 | 0.047 | 0.409 | Antithrombotic | | |
| 0.359 | 0.028 | 0.359 | DNA synthesis inhibitor | | |
| 0.361 | 0.054 | 0.361 | 5 Hydroxytryptamine release stimulant | | |
| 0.341 | 0.038 | 0.341 | Hypolipemic | | |
| 0.361 | 0.069 | 0.361 | Vasodilator, peripheral | | |
| 0.303 | 0.012 | 0.303 | Anesthetic local | | |
| 0.294 | 0.01 | 0.294 | Cathepsin H inhibitor | | |
| 0.279 | 0.033 | 0.279 | P-glycoprotein inhibitor | | |
| 0.265 | 0.022 | 0.265 | Acetylcholine M1 receptor antagonist | | |
| 0.332 | 0.095 | 0.332 | Calpain 2 inhibitor | | |
| 0.252 | 0.016 | 0.252 | Alkylator | | |
| 0.274 | 0.045 | 0.274 | Calpain inhibitor | | |
| 0.305 | 0.077 | 0.305 | Immunostimulant | | |
| 0.312 | 0.084 | 0.312 | Cholesterol antagonist | | |
| 0.226 | 0.003 | 0.226 | Protease 3C (Human rhinovirus) inhibitor | | |
| 0.263 | 0.045 | 0.263 | Anesthetic general | | |
| 0.227 | 0.014 | 0.227 | Microtubule formation inhibitor | | |
| 0.27 | 0.07 | 0.27 | Cardiotonic | | |
| 0.23 | 0.031 | 0.23 | Thiol protease inhibitor | | |
| 0.265 | 0.067 | 0.265 | 5 Hydroxytryptamine uptake stimulant | | |
| 0.205 | 0.014 | 0.205 | Catalase inhibitor | | |
| 0.196 | 0.015 | 0.196 | Protease inhibitor | | |
| 0.291 | 0.122 | 0.291 | GABA C receptor rho-3 antagonist | | |
| 0.191 | 0.027 | 0.191 | Acetylcholine muscarinic antagonist | | |
| 0.189 | 0.025 | 0.189 | Farnesoid X receptor antagonist | | |
| 0.173 | 0.01 | 0.173 | Factor V inhibitor | | |
| 0.175 | 0.016 | 0.175 | Sphingomyelinase inhibitor | | |
| 0.169 | 0.011 | 0.169 | Acetylcholine M3 receptor agonist | | |
| 0.175 | 0.017 | 0.175 | Calcium antagonist | | |
| 0.182 | 0.024 | 0.182 | Adenylate cyclase stimulant | | |
| 0.266 | 0.111 | 0.266 | Sodium/bile acid cotransporter inhibitor | | |
| 0.177 | 0.025 | 0.177 | Nav1.4 sodium channel blocker | | |
| 0.18 | 0.032 | 0.18 | Proteasome inhibitor | | |
| 0.182 | 0.039 | 0.182 | Cell wall synthesis inhibitor | | |
| 0.22 | 0.084 | 0.22 | Angiogenesis stimulant | | |
| 0.3 | 0.166 | 0.3 | 5 Hydroxytryptamine release inhibitor | | |
| 0.187 | 0.054 | 0.187 | Phospholipase C inhibitor | | |
| 0.171 | 0.042 | 0.171 | Cholinergic antagonist | | |
| 0.132 | 0.007 | 0.132 | Acetyl-CoA transferase inhibitor | | |
| 0.229 | 0.106 | 0.229 | Gastrin inhibitor | | |
| 0.139 | 0.024 | 0.139 | Acetylcholine nicotinic antagonist | | |
| 0.16 | 0.045 | 0.16 | Acetylcholine antagonist | | |
| 0.218 | 0.107 | 0.218 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.203 | 0.095 | 0.203 | RNA-directed DNA polymerase inhibitor | | |
| 0.147 | 0.041 | 0.147 | Vanilloid 1 agonist | | |
| 0.152 | 0.047 | 0.152 | Cyclooxygenase 3 inhibitor | | |
| 0.119 | 0.016 | 0.119 | Carbamoyl phosphate synthetase inhibitor | | |
| 0.158 | 0.055 | 0.158 | Histone deacetylase SIRT1 inhibitor | | |
| 0.208 | 0.109 | 0.208 | DNA damaging | | |
| 0.11 | 0.014 | 0.11 | Ornithine carbamoyltransferase inhibitor | | |
| 0.119 | 0.024 | 0.119 | Somatostatin 1 agonist | | |
| 0.12 | 0.025 | 0.12 | Transcription factor NF kappa B stimulant | | |
| 0.12 | 0.026 | 0.12 | Ornithine decarboxylase inhibitor | | |
| 0.166 | 0.075 | 0.166 | Growth hormone agonist | | |
| 0.093 | 0.005 | 0.093 | Cathepsin K inhibitor | | |
| 0.093 | 0.006 | 0.093 | Glutamate (mGluR1a) antagonist | | |
| 0.145 | 0.058 | 0.145 | Alpha-N-acetylglucosaminidase inhibitor | | |
| 0.1 | 0.016 | 0.1 | Cathepsin B inhibitor | | |
| 0.129 | 0.048 | 0.129 | Falcipain 3 inhibitor | | |
| 0.092 | 0.013 | 0.092 | Nitric oxide donor | | |
| 0.098 | 0.021 | 0.098 | Cathepsin L inhibitor | | |
| 0.088 | 0.011 | 0.088 | Leukocyte elastase inhibitor | | |
| 0.087 | 0.014 | 0.087 | Elastase inhibitor | | |
| 0.105 | 0.033 | 0.105 | Chymotrypsin inhibitor | | |
| 0.113 | 0.042 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | | |
| 0.091 | 0.021 | 0.091 | Beta adrenoreceptor antagonist | | |
| 0.111 | 0.042 | 0.111 | Antineoplastic antibiotic | | |
| 0.08 | 0.011 | 0.08 | HCV NS3/NS4A protease inhibitor | | |
| 0.087 | 0.019 | 0.087 | Caspase 9 inhibitor | | |
| 0.079 | 0.011 | 0.079 | Cathepsin L2 inhibitor | | |
| 0.082 | 0.017 | 0.082 | Beta 1 adrenoreceptor antagonist | | |
| 0.085 | 0.021 | 0.085 | Human rhinovirus A protease inhibitor | | |
| 0.081 | 0.016 | 0.081 | Toll-Like receptor 2 agonist | | |
| 0.098 | 0.036 | 0.098 | 3C-Like protease (SARS coronavirus) inhibitor | | |
| 0.081 | 0.019 | 0.081 | Bombesin 3 receptor antagonist | | |
| 0.179 | 0.118 | 0.179 | Platelet antagonist | | |
| 0.083 | 0.021 | 0.083 | Acyl-CoA dehydrogenase inhibitor | | |
| 0.118 | 0.059 | 0.118 | GABA receptor agonist | | |
| 0.154 | 0.095 | 0.154 | ATPase inhibitor | | |
| 0.095 | 0.039 | 0.095 | Histamine H2 receptor antagonist | | |
| 0.156 | 0.101 | 0.156 | Succinate dehydrogenase inhibitor | | |
| 0.139 | 0.083 | 0.139 | Hemostatic | | |
| 0.065 | 0.009 | 0.065 | HIV-1 protease inhibitor | | |
| 0.062 | 0.008 | 0.062 | Acetyl-CoA transferase 1 inhibitor | | |
| 0.071 | 0.018 | 0.071 | Acetylcholine M2 receptor agonist | | |
| 0.088 | 0.037 | 0.088 | GABA aminotransferase inhibitor | | |
| 0.112 | 0.061 | 0.112 | GABA C receptor antagonist | | |
| 0.107 | 0.057 | 0.107 | Adenylate kinase inhibitor | | |
| 0.061 | 0.014 | 0.061 | Acetyl-CoA carboxylase inhibitor | | |
| 0.051 | 0.005 | 0.051 | Glutamate (mGluR1) agonist | | |
| 0.06 | 0.014 | 0.06 | Microtubule stabilization | | |
| 0.081 | 0.035 | 0.081 | Sirtuin 1 inhibitor | | |
| 0.207 | 0.163 | 0.207 | Transcription factor NF kappa B inhibitor | | |
| 0.172 | 0.129 | 0.172 | 5 Hydroxytryptamine 3E antagonist | | |
| 0.059 | 0.016 | 0.059 | Cathepsin L1 inhibitor | | |
| 0.103 | 0.06 | 0.103 | Folate antagonist | | |
| 0.053 | 0.011 | 0.053 | Bombesin 1 receptor antagonist | | |
| 0.063 | 0.021 | 0.063 | Beta 2 adrenoreceptor antagonist | | |
| 0.046 | 0.004 | 0.046 | HCV NS5A inhibitor | | |
| 0.057 | 0.016 | 0.057 | Cytokine production stimulant | | |
| 0.053 | 0.016 | 0.053 | Renin inhibitor | | |
| 0.044 | 0.008 | 0.044 | HCV polyprotein inhibitor | | |
| 0.08 | 0.044 | 0.08 | Cathepsin G inhibitor | | |
| 0.157 | 0.121 | 0.157 | Platelet aggregation inhibitor | | |
| 0.162 | 0.129 | 0.162 | Aldehyde oxidase inhibitor | | |
| 0.061 | 0.03 | 0.061 | Sphingosine kinase 2 inhibitor | | |
| 0.065 | 0.034 | 0.065 | Cathepsin E inhibitor | | |
| 0.06 | 0.031 | 0.06 | Acetyl-CoA transferase 2 inhibitor | | |
| 0.058 | 0.029 | 0.058 | Alpha-mannosidase inhibitor | | |
| 0.144 | 0.117 | 0.144 | Neurotensin receptor agonist | | |
| 0.062 | 0.035 | 0.062 | Ribonucleotide reductase inhibitor | | |
| 0.035 | 0.009 | 0.035 | Vasopressin 1A agonist | | |
| 0.128 | 0.102 | 0.128 | Thrombolytic | | |
| 0.06 | 0.034 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | | |
| 0.049 | 0.024 | 0.049 | Geranyltranstransferase inhibitor | | |
| 0.04 | 0.015 | 0.04 | Acetylcholine M4 receptor agonist | | |
| 0.054 | 0.029 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | | |
| 0.056 | 0.032 | 0.056 | 5 Hydroxytryptamine 1B agonist | | |
| 0.031 | 0.01 | 0.031 | Lysophosphatidic acid receptor 1 agonist | | |
| 0.042 | 0.02 | 0.042 | Arginase inhibitor | | |
| 0.035 | 0.014 | 0.035 | Elastase 3B inhibitor | | |
| 0.035 | 0.014 | 0.035 | Elastase 3A inhibitor | | |
| 0.035 | 0.014 | 0.035 | Elastase 2B inhibitor | | |
| 0.051 | 0.03 | 0.051 | Antimetabolite | | |
| 0.036 | 0.015 | 0.036 | Glutamate (mGluR3) agonist | | |
| 0.037 | 0.016 | 0.037 | Peptide deformylase inhibitor | | |
| 0.11 | 0.09 | 0.11 | Toll-Like receptor 2 antagonist | | |
| 0.05 | 0.03 | 0.05 | Bombesin antagonist | | |
| 0.036 | 0.017 | 0.036 | Calpain 1 inhibitor | | |
| 0.062 | 0.043 | 0.062 | Beta 2 adrenoreceptor agonist | | |
| 0.062 | 0.044 | 0.062 | Histone deacetylase SIRT3 inhibitor | | |
| 0.04 | 0.022 | 0.04 | Tryptase inhibitor | | |
| 0.106 | 0.09 | 0.106 | Nav1.3 sodium channel blocker | | |
| 0.026 | 0.01 | 0.026 | Cathepsin S inhibitor | | |
| 0.067 | 0.051 | 0.067 | Exportin-1 inhibitor | | |
| 0.091 | 0.076 | 0.091 | GABA C receptor rho-1 antagonist | | |
| 0.088 | 0.074 | 0.088 | Aminopeptidase B inhibitor | | |
| 0.054 | 0.042 | 0.054 | Argininosuccinate synthase inhibitor | | |
| 0.018 | 0.006 | 0.018 | Lysophosphatidic acid receptor 3 agonist | | |
| 0.037 | 0.026 | 0.037 | Cholecystokinin A antagonist | | |
| 0.051 | 0.041 | 0.051 | Cathepsin D inhibitor | | |
| 0.056 | 0.048 | 0.056 | Acetylcholine M2 receptor antagonist | | |
| 0.066 | 0.058 | 0.066 | Aminopeptidase I inhibitor | | |
| 0.043 | 0.035 | 0.043 | Mannosidase inhibitor | | |
| 0.063 | 0.056 | 0.063 | Glutamate (mGluR6) antagonist | | |
| 0.13 | 0.123 | 0.13 | Ca2+-transporting ATPase inhibitor | | |
| 0.024 | 0.018 | 0.024 | 5 Hydroxytryptamine 4 agonist | | |
| 0.048 | 0.043 | 0.048 | Glucose-6-phosphate translocase inhibitor | | |
| 0.033 | 0.029 | 0.033 | Ceramide glucosyltransferase inhibitor | | |
| 0.082 | 0.078 | 0.082 | Prolactin inhibitor | | |
| 0.035 | 0.032 | 0.035 | Cholecystokinin antagonist | | |
| 0.06 | 0.057 | 0.06 | Phosphofructokinase-1 inhibitor | | |
| 0.083 | 0.08 | 0.083 | Glutamate release inhibitor | | |
| 0.02 | 0.018 | 0.02 | Elastase 2 inhibitor | | |
| 0.02 | 0.018 | 0.02 | Elastase 2A inhibitor | | |
| 0.048 | 0.047 | 0.048 | Vanilloid 2 antagonist | | |
| 0.083 | 0.082 | 0.083 | Creatine kinase inhibitor | | |